COMMUNIQUÉS West-GlobeNewswire

Globus Medical Reports Preliminary Record Fourth Quarter and Full Year Sales Results
07/01/2026
AUDUBON, Pa., Jan. 07, 2026 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal solutions company, today announced preliminary unaudited sales results for the fourth quarter and full year [...]
Onco360® Has Partnered with Rigel Pharmaceuticals to Add Three Therapies to Its Limited Distribution Portfolio
07/01/2026
LOUISVILLE, Ky., Jan. 07, 2026 (GLOBE NEWSWIRE) -- Onco360 ® , the nation’s leading independent specialty pharmacy, has been chosen by Rigel Pharmaceuticals as limited distribution specialty pharmacy partner for [...]
Jasper Therapeutics Appoints Jeet Mahal as Chief Executive Officer to Lead Next Phase of Clinical Growth
07/01/2026
Thomas Wiggans appointed Executive Chairperson Jasper to host an investor webinar on January 8 th at 8:00am ET to present updated data from the BEACON study in CSU and the open-label extension study in CSU and CIndU [...]
Park Dental Partners Completes Acquisitions of Two Practices - Enters Phoenix Market and Expands Twin Cities Presence
07/01/2026
MINNEAPOLIS, Jan. 07, 2026 (GLOBE NEWSWIRE) -- Park Dental Partners, Inc. (NASDAQ: PARK) (the Company), a leading dental resource organization, announced the completion of two general dentistry practice acquisitions on [...]
Built In Honors Xealth as a Top 10 Best Startup to Work for in Seattle
07/01/2026
Xealth Earns High Ranking on Built In’s Esteemed 2026 Best Places to Work Awards SEATTLE, Jan. 07, 2026 (GLOBE NEWSWIRE) -- Xealth , the leading digital health platform that brings diverse digital tools and care [...]
MESA LABS DECLARES QUARTERLY DIVIDEND
07/01/2026
LAKEWOOD, Colo., Jan. 07, 2026 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB) (we, us, our, “Mesa” or the “Company”) today announced that its Board of Directors has declared a regular quarterly dividend of $0 [...]
Correction: Transactions of Managers and Closely Associated Persons
07/01/2026
Attached are copies of two filings with the Luxembourg Commission de Surveillance du Secteur Financier (CSSF) regarding transactions of managers and closely associated persons. ATP Holdings ehf. announced two [...]
LENZ Therapeutics Reports Fourth Quarter 2025 Preliminary Unaudited Financial Results and Recent Corporate Updates
07/01/2026
Launched VIZZ™ (aceclidine ophthalmic solution) 1.44% in October 2025 for the treatment of presbyopia, with broad product availability in mid-November 2025 Achieved approximately $1.6 million in net product revenue with [...]
Range Impact Announces Two Major Land Acquisitions in Kentucky and Sale of Abandoned Mine Land Services Business
07/01/2026
CLEVELAND, OHIO, Jan. 07, 2026 (GLOBE NEWSWIRE) -- Range Impact, Inc. (OTCQB: RNGE) (“Range Impact” or the “Company”), a public company dedicated to acquiring, reclaiming and repurposing distressed coal mine properties [...]
Neocis Surpasses 100,000 Robotic Osteotomies with the Yomi Platform
07/01/2026
Landmark milestone demonstrates proven robotic adoption as the next generation Yomi S completes the first real world cases MIAMI, Jan. 07, 2026 (GLOBE NEWSWIRE) -- Neocis, the market leader behind the Yomi® robotic [...]
National Institutes of Health Awards $1.54M Grant To Scottish Rite for Children for Rare Diseases Research
07/01/2026
Promising Hydrogel Could Help Kids Walk Again and Adults Avoid Invasive Surgery Dallas, Jan. 07, 2026 (GLOBE NEWSWIRE) -- Every year, thousands of children and adults face the crippling effects of osteonecrosis. Now, [...]
GENFIT annonce son calendrier financier pour 2026
07/01/2026
Lille (France), Cambridge (Massachusetts, États-Unis), Zurich (Suisse), le 7 janvier 2026 – GENFIT (Euronext : GNFT) , société biopharmaceutique de stade clinique avancé engagée dans l’amélioration de la vie des [...]
GENFIT Announces 2026 Financial Calendar
07/01/2026
Lille (France), Cambridge (Massachusetts, United States), Zurich (Switzerland), January 7, 2026 - GENFIT (Euronext: GNFT) , a late-stage biopharmaceutical company dedicated to improving the lives of patients with rare [...]
Comprehensive Healthcare Welcomes Community Behavioral Health Veteran as Chief Medical Officer
07/01/2026
YAKIMA, Wash., Jan. 07, 2026 (GLOBE NEWSWIRE) -- Comprehensive Healthcare, the leading community behavioral health provider in Central and Southwest Washington, is proud to welcome Mark Bradshaw, M.D., as its new chief [...]
AB Science annonce un quatrième cas consécutif de réponse avec la combinaison d’AB8939 et du venetoclax dans le traitement de la leucémie myéloïde aiguë réfractaire ou en rechute, sur la base des données de phase 1
07/01/2026
COMMUNIQUÉ DE PRESSE AB SCIENCE ANNONCE UN QUATRIÈME CAS CONSÉCUTIF DE RÉPONSE AVEC LA COMBINAISON D’AB8939 ET DU VENETOCLAX DANS LE TRAITEMENT DE LA LEUCÉMIE MYÉLOÏDE AIGUË RÉFRACTAIRE OU EN RECHUTE, SUR LA BASE DES [...]
AB Science reports fourth consecutive case of response from Phase 1 data for the combination of AB8939 with venetoclax for the treatment of refractory or relapsed acute myeloid leukemia
07/01/2026
PRESS RELEASE AB SCIENCE REPORTS FOURTH CONSECUTIVE CASE OF RESPONSE FROM PHASE 1 DATA FOR THE COMBINATION OF AB8939 WITH VENETOCLAX FOR THE TREATMENT OF REFRACTORY OR RELAPSED ACUTE MYELOID LEUKEMIA The combination [...]
300 Exceptional Teen Scientists Recognized for Innovative STEM Research in Nation’s Oldest and Most Prestigious High School Competition
07/01/2026
Regeneron Science Talent Search Marks Milestone 85th Year with $1.2 Million Awarded to Nation’s Most Promising Young Scientists and Their Schools WASHINGTON, Jan. 07, 2026 (GLOBE NEWSWIRE) -- Society for Science (the [...]
Ipsen - Décembre 2025 - Information mensuelle relative au nombre total des droits de vote et d’actions composant le capital social
07/01/2026
Information mensuelle relative au nombre total des droits de vote et d’actions composant le capital social (conformément à l’article L.233-8 II du Code de commerce et à l’article 223-16 du Règlement Général de l’ [...]
Ipsen - December 2025 - Monthly information relative to the total number of voting rights and shares composing the share capital
07/01/2026
Monthly information relative to the total number of voting rights and shares composing the share capital (in accordance with Article L.233-8 II of the French Commercial Code and Article 223-16 of the General Regulation [...]

Pages